InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sachs David C., Chief Financial Officer. Officer active across 1 companies, notably ImmunityBio, Inc.. Cumulatively, 4 reports have been logged. The latest transaction was filed on 9 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations4 total
017,242 shares0
Common Stock
SEC:0001326110-21-000012·
017,242 shares0
Common Stock
SEC:0001326110-21-000012:0·
07,598 shares0
Common Stock
SEC:0001209191-21-055786·
07,598 shares0
Common Stock
SEC:0001209191-21-055786:0·
4 of 4 declarations
About Sachs David C.
David C. Sachs is the Chief Financial Officer of ImmunityBio, Inc. In this role, he oversees all financial activities of the company, including budgeting, financial analysis, and investment management. His expertise in finance is essential to support ImmunityBio's growth and profitability. David C. Sachs also contributes to the company's overall strategy by providing accurate financial analyses and strategic advice.
